Aisling Capital

https://www.aislingcapital.com
Last activity: 24.04.2022
Tags:DevelopmentProductDrugMedTechMedicalHealthPharmacyBiopharmaBioTechTechnology
Aisling Capital is a leading life science investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies.
News
578
Team
13
Portfolio
109
References
21
Member count:11-50

News 578

DateTitleDescription_References
20.12.2021ObsEva Add...GENEVA, Switzerland – December...-
14.12.2021Antios The...MENDHAM, NJ and WARMINSTER, PA...-
22.11.2021Obseva Ann...FDA Accepts NDA for Linzagolix...-
03.11.2021Antios The...Financing round was co-led by ...-
21.10.2021Harmony Bi...PLYMOUTH MEETING, PA – Oct. 21...-
12.10.2021Poseida Th...Collaboration to leverage Pose...-
27.09.2021Syndax Pha...Syndax to receive $ 152 millio...-
23.09.2021Garuda The...First off-the-shelf, long-term...-
27.07.2021BridgeBio ...First clinical combination stu...-
15.07.2021Wugen Rais...Proceeds to advance clinical d...-
Show more

Team 13

DateNameTitleDescription
-Andrew Sch...Managing P...Dr. Schiff joined Aisling in 2...
-Sunny Redd...AssociateSunny joined Aisling in 2019 a...
-Stacey D. ...PartnerMs. Seltzer joined Aisling in ...
-Eric Aguia...PartnerDr. Aguiar joined Aisling in 2...
-Aftab Kher...Operating ...Dr. Kherani joined Aisling in ...
-Hannah Wie...ControllerMs. Wieder joined Aisling in 2...
-Robert Wen...Chief Fina...Mr. Wenzel joined Aisling in 2...
-Dr. J.H. B...Operating ...Dr. Bilenker joined Aisling in...
-Carol Ziko...Head of Hu...Ms. Zikopoulos joined Aisling ...
-Steven Elm...Managing P...Mr. Elms joined Aisling in 200...
Show more

Portfolio 109

DateNameDescriptionCategoryWebsiteLocationStatus
24.04.2022Wugen, Inc...Wugen, Inc., is a clinical-sta...Biopharmawugen.com/St. Louis,...Current
24.04.2022Garuda The...Garuda Therapeutics seeks to c...Biopharmagarudatx.c...Cambridge,...Current
07.07.2021Biomea Fus...Biomea Fusion is a preclinical...Biopharmabiomeafusi...Redwood Ci...Current
07.07.2021Reneo Phar...Reneo is a clinical stage phar...Biopharmareneopharm...San Diego,...Current
07.07.2021Treeline B...-Biopharmatreelinebi...Stamford, ...Current
07.07.2021Antios The...Antios Therapeutics is a clini...Biopharmaantiosther...Atlanta, G...Current
-Atreca, In...Biotechnology company developi...Biopharmaatreca.com...Redwood Ci...Current
-Archimica ...Manufacturer of active pharmac...Serviceseuticals.c...Amsterdam,...Acquired
-Agile Ther...Women's health specialty pharm...Biopharmaagilethera...Princeton,...Current
-Oculex Pha...Ophthalmic drug delivery compa...Medical De...allergan.c...Sunnyvale,...Acquired
Show more

Mentions in press and media 21

DateTitleDescriptionCategoryAuthorSource
09.02.2022Novo Holdi...January 3, 2022: Novo Holdings...--courtsquar...
09.07.2018CONVERGE P...In a Q&A, Griffith-Gryga h...--medcitynew...
02.11.2017Aisling Ca...Aisling Capital, a late-stage ...--citybizlis...
02.11.2017Term Sheet...SKY HIGH Good morning, Term S...--fortune.co...
02.11.2017Aisling Ca...Aisling Capital, a NYC-based l...USA-finsmes.co...
02.11.2017Aisling Ca...NEW YORK, Nov. 2, 2017 /PRNews...--aislingcap...
18.07.2017F-Prime Ca...Menlo Therapeutics Inc. announ...--citybizlis...
18.07.2017Rock Sprin...Menlo Therapeutics Inc. announ...--citybizlis...
13.01.2016Daily fund...Zerto secured $50M; Syros Phar...-Mitos Suso...vator.tv/n...
06.01.2016Aisling Ca...Aisling Capital, a NYC-based i...USA-finsmes.co...
Show more